Verition Fund Management’s Longevity Health Holdings XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-339
Closed -$105K – 2745
2023
Q2
$105K Hold
339
– – ﹤0.01% 1971
2023
Q1
$103K Hold
339
– – ﹤0.01% 1909
2022
Q4
$101K Hold
339
– – ﹤0.01% 1851
2022
Q3
$99K Buy
+339
New +$98.9K ﹤0.01% 2625
2022
Q2
– Sell
-339
Closed -$99K – 3177
2022
Q1
$99K Hold
339
– – ﹤0.01% 2434
2021
Q4
$98K Buy
+339
New +$98.8K ﹤0.01% 2346

Other funds holding XAGE

Verition Fund Management's XAGE Position: Q3 2023 in Review

Verition Fund Management sold out of Longevity Health Holdings (XAGE) in Q3 2023, closing a stake of 339 shares — an estimated $105K sold.

Verition Fund Management first reported a position in XAGE in Q4 2021 and held it in 6 quarters. The position peaked at $105K in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Verition Fund Management reported no remaining Longevity Health Holdings position as of Q3 2023 after selling out during the quarter.
  • Verition Fund Management sold 339 Longevity Health Holdings shares in Q3 2023, an estimated $105K.
  • Verition Fund Management first reported a position in Longevity Health Holdings in Q4 2021 and held it in 6 quarters.
  • Verition Fund Management's Longevity Health Holdings position peaked at $105K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.